Inventor
RAY TABIBIAZAR
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
C12NMicroorganisms or enzymes24%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C40BCombinatorial chemistry16%
PatentTitleYear
12,570,750Antibodies that bind adenosine A2A receptors and methods of use thereof to treat cancer and neurological diseases202612,331,427Antibodies that bind GLP1R202512,091,777Variant nucleic acid libraries for CRTH2202411,993,784Transposition-based therapies202411,542,528Transposition-based therapies202311,492,727Variant nucleic acid libraries for GLP1 receptor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to TWIST BIOSCIENCE CORP (4)· patent assignee history
2022–2026Based in US· patent location history
2023–2024Patents assigned to SALIOGEN THERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TWIST BIOSCIENCE CORP | 4 | 2022–2026 |
| SALIOGEN THERAPEUTICS INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |